Outcome of Wide Local Excision and V-Y Plasty for Axillary Hidradenitis Suppurativa
DOI:
https://doi.org/10.14738/bjhmr.105.15465Abstract
Background: Hidradenitis suppurativa (HS) is a chronic, relapsing, inflammatory skin condition that greatly affects patients’ quality of life. The patient with HS presents with inflammation of hair follicles in the apocrine gland-bearing regions (armpits, genital area, groin, inframammary region, perianal region and buttocks). It can be associated with fistulating sinus, scarring and abscesses formation. We present our experience of treating axillary HS by wide local excision and V-Y plasty advancement flap. Methods: A retrospective analysis reviewed 23 patients, out of which 21 were female and 3 were male. Age range was 17 to 31 years. All were having axillary HS. Five patients were having bilateral disease. 19 patients had one stage V-Y plasty. Only 4 patients had severe infections and multiple abscess formation at the time of Wide excision. They were managed by 2 stage procedure. Wide excision first and secondary flap coverage after 10 days. They were followed for 1 year for recurrence of the disease. Results: Average post operative hospital stay was 6 days. 3 patients had wound infections which did not require any secondary procedure.21 patients showed no recurrence after surgery. 2 patients had minor recurrence at the periphery of the axilla of the flap coverage. They did not require further surgical procedure. There was no contracture. All had full range of movement of the shoulder. Conclusion: Wide local excision is the best surgical treatment for advanced HS. V-Y plasty advancement flap from the inner aspect of the arm is a very easy procedure to cover axillary skin loss. The procedure has a very low recurrence. The mobility of the shoulder joint is unaffected.
References
Verneuil AS: Etudes sur les tumeurs de la peau et quelques maladies de glandes sudoripares. Arch Gen Med 1854, 94: 693–705.
Plewig G, Steger M: Acne inversa (alias acne triad, acne tetrad or hidradenitis suppurativa). Martin Dunitz, London; 1989:345–57.
Scheinfeld N: Hidradenitis should not be renamed acne inversa. Dermatol. Online J 2006,12(7):6.
Balik E, Eren T, Bulut T, Büyükuncu Y, Bugra D, Yamaner S: Surgical Approach to Extensive Hidradenitis Suppurativa in the Perineal/Perianal and Gluteal Regions. World J Surg 2009, 33: 481–487. 10.1007/s00268-008-9845-9
Yazdanyar S, Jemec GB: Hidradenitis suppurativa: a review of cause and treatment. Curr Opin Infect Dis 2011,24(2):118–23. 10.1097/QCO.0b013e3283428d07
Slade EM, Powell BW, Mortimer PS: Hidradenitis suppurativa: pathogenesis and management. Brit Assoc Plastic Surg 2003, 56: 451–41.
Revuz J: Hidradenitis suppurativa. Presse Med 2010,39(12):1254–64. 10.1016/j.lpm.2010.08.003
Tanaka A, Hatoko M, Tada H, Kuwahara M, Mashiba K, Yurugi S: Experience with surgical treatment of hidradenitis suppurativa. Ann Plast Surg 2001, 47: 636–642. 10.1097/00000637-200112000-00010
Matusiak Ł, Bieniek A, Szepietowski JC: Soluble interleukin-2 receptor serum level is a useful marker of hidradenitis suppurativa clinical staging. Biomarkers 2009,14(6):432–7. 10.1080/13547500903075218
Kagan RJ, Yakuboff KP, Warner P, Warden GD: Surgical treatment of hidradenitis suppurativa: A 10-year experience. Surgery 2005, 138: 734–41. 10.1016/j.surg.2005.06.053
Sartorius K, Lapins J, Emtestam L, Jemec GB: Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatoll 2003,149(1):211–213. 10.1046/j.1365-2133.2003.05390.
Thielen AM, Barde C, Saurat JH: Long-term infliximab for severe hidradenitis Suppurativa. British Journal of Dermatology 2006, 154: 1074–1208.
Menderes M, Sunay O, Vayvada H, Yilmaz M: Surgical Management of Hidradenitis Suppurativa. Int. J. Med. Sci 2010,7(4):240–24.
Mitchell KM, Beck DE: Hidradenitis suppurativa. Surg Clin North Am 2002,82(6):1187–97. 10.1016/S0039-6109(02)00060-9
Büyükaşik O, Hasdemir AO, Kahramansoy N, Cöl C, Erkol H: Surgical Approach to Extensive Hidradenitis Suppurativa. Dermatol Surg 2011,37(6):835–42. 10.1111/j.1524-4725.2011. 01961..x 134
Conway H, Stark RB, Climo S, Weeter JC, Garcia FA: The surgical treatment of chronic hidradenitis suppurativa. Surg Gynecol Obstet 1952,95(4):455–64.
Bieniek A, Matusiak L, Okulewicz-Gojlik D, Szepietowski JC: Surgical treatment of hidradenitis suppurativa:
Rompel R, Petres J: Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa. Dermatol Surg 2000,26(7):638–43. 10.1046/j.1524-4725.2000.00043.
Bohn J, Svensson H: Surgical treatment of hidradenitis suppurativa. Scand J Plast Reconstr Surg Hand Surg 2001,35(3):305–9. 10.1080/028443101750523230
Sharma RK, Kapoor KM, Singh G: Reconstruction in extensive axillary hidradenitis suppurativa with local fasciocutaneous V-Y advancement flaps. Ind J. Plast. Surj 2006, 39–1: 81–21.
Geh JL, Niranjan NS: Perforator-based fasciocutaneous island flaps for the reconstruction of axillary defects following excision of hidradenitis suppurativa. Br J Plast Surg 2002,55(2):124–8. 10.1054/bjps.2001.3783
Chuang CJ, Lee CH, Chen TM, Wang HJ, Chen SG: Use of a versatile transpositional flap in the surgical treatment of axillary hidradenitis suppurativa. J Formos Med Assoc 2004,103(8):644–7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Sardar Rezaul Islam, Mohammad Hanif Emon, Shah Alam Sarkar, Debabroto Paul
This work is licensed under a Creative Commons Attribution 4.0 International License.
